Companion Animal Specialty Drug Market Is Likely to Envisage a Steady CAGR of 3.9% in Revenue Terms During the Forecast Period 2016-2026
Increase in the availability of treatments for companion animals, driven by the larger availability of drugs, is fuelling the demand for companion animal specialty drugs, according to a new study by FMI
View full press release